Utah
The Board of Pharmacy posted the following:
- September 27 Approved Minutes
- November 15 Meeting – Agenda, audio recording and handouts
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Washington
The House Health Care and Wellness Committee is holding a work session on December 1 to take written and virtual testimony on pharmacy benefit manager impacts on prescription drug costs. NACDS will provide members with the agenda and our comment letter before the hearing.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Alabama
Pharmacist registrations expire December 31, 2022. The Board of Pharmacy is accepting pharmacist license renewals ONLINE ONLY at www.albop.com. The renewal fee is $100 plus $100 for a controlled substance permit. If you are changing your name, send proof of legal name change BEFORE YOU REGISTER ONLINE. If you fail to renew your license by December 31, 2022, but you continue to work as a pharmacist in any way, you will be subject to late fees and discipline. For more information, please contact the Board of Pharmacy directly at 205-981-2280.
Also in Alabama, please see these updated ALERTS for billing for Stand-alone COVID-19 Vaccine Counseling for Recipients Under Age 21 and billing for Stand-alone Vaccine Counseling to Recipients Under Age 21.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Alaska
The Board of Pharmacy's statutes and regulations booklet has been updated to reflect sections 1 – 10 of HB 145, the new pharmacist and pharmacy technicians expanded practice law passed this year. The October 2022 booklet reflects these changes to AS 08.80:
- Permits pharmacists to engage in independent monitoring of drug therapy;
- Clarifies pharmacists can independently prescribe and administer vaccines, related emergency medications, and opioid overdose drugs;
- Permits pharmacy technicians to administer vaccines or related emergency medications, if approved by the board;
- Requires interns and technicians to disclose prescription drug prices;
- Permits pharmacists to provide patient care services outside of a collaborative practice agreement with a physician for general health and wellness, disease prevention and certain conditions, including conditions that involve CLIA-waived tests;
- Removes dosage form from equivalent drug product and
- Updates the definition of "practice of pharmacy"
For more information, contact NACDS’ Mary Staples at 817-442-1155.
California
The Board of Pharmacy has announced an additional meeting of the Standard of Care Ad Hoc Committee schedule for November 16 and posted an agenda for the meeting.
Also in California, the Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal. Please note the Medi-Cal recoupment announcement in "Recommencement of Pharmacy Retroactive Claims Adjustments" document; these recoupments are set to begin in January 2023.
- Medical Supplies: Correction to Limitations for Contraceptive Supply (November 3)
- Medi-Cal Rx Monthly Bulletin for November (November 1)
- Changes to the Contract Drugs List (CDL) (November 1)
- Changes to the Contract Drugs List (CDL) – Over-the-Counter Drugs (November 1)
- Updates to the Medi-Cal Rx Provider Manual (November 1)
- Recommencement of Pharmacy Retroactive Claim Adjustments in November 2022 (October 31)
- Prior Authorization Appeals and Claim Appeals: A Reminder for Providers (October 28)
- Medi-Cal Rx Weekly Wrap-Up for October 21-27 (October 28)
Finally in California, Medi-Cal posted the following:
- Paper RADs, No Pay Documents and EFT Statements Will Soon be Replaced by Electronic Equivalents (November 1)
- Medi-Cal News: Coming Soon: Booster Dose for Novavax and Pediatric Bivalent Pfizer-BioNTech and Moderna COVID-19 Vaccines (October 31)
- Medi-Cal Rx Update – Pharmacy – October 2022 – Bulletin 1026 (October 31)
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Florida
As of September 29, 2022, the Federal Emergency Management Agency (FEMA) issued a major disaster declaration for the following Florida counties affected by Hurricane Ian (DR-4673): Brevard, Charlotte, Collier, DeSoto, Flagler, Glades, Hardee, Hendry, Highlands, Hillsborough, Lake, Lee, Manatee, Monroe, Okeechobee, Orange, Osceola, Palm Beach, Pasco, Pinellas, Polk, Putnam, Sarasota, Seminole, St. Johns, and Volusia.
The Agency for Health Care Administration (Agency) announced it will ensure reimbursement for all services provided in good faith to eligible Florida Medicaid recipients in FEMA designated counties during the Disaster Grace Period. The Agency is defining the Disaster Grace Period for Hurricane Ian as September 29, 2022 through November 30, 2022.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Illinois
This notice implements the section of Public Act 102-0103 that allows pharmacists to bill and be reimbursed for patient care services for hormonal contraceptives. This new policy is effective with dates of service on and after August 1, 2022, and applies to the Medicaid fee-for-service (FFS) program and the HealthChoice Illinois (HCI) managed care organization (MCO) plans.
Also in Illinois, this notice provides an update on coverage of the new COVID-19 bivalent boosters. The update applies to claims for customers covered under traditional Medicaid fee-for-service (FFS) and the HealthChoice Illinois (HCI) managed care organization (MCO) plans.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Kentucky
Magellan published a provider notice outlining September Preferred Drug List changes in Medicaid.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Louisiana
The Board of Pharmacy quarterly meeting is scheduled on November 15 and 16 at the Board's office in Baton Rouge. Prior to the meeting, the agenda and public meeting binder will be accessible here.
Also in Louisiana, Gov. John Bel Edwards (D) appointed 5 members to the 17-member Board of Pharmacy.
- Ricky Indovina, pharmacist with Ochsner Health System to a third six-year term;
- Raymond Strong, PharmD, with Ascension DePaul Services to a second six-year term;
- Pharmacist Jennifer Elliott Dupree with Walmart, a new member to a six-year term;
- Richard Mannino, independent pharmacy owner to a second six-year term and
- Chris Melancon, a new independent staff pharmacist to a six-year term.
Finally in Louisiana, on October 19th, the Medicaid Fee for Service (FFS) Pharmacy Program announced the implementation of an electronic drug prior authorization application to achieve a more streamlined authorization process.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Minnesota
NACDS reminds members that the mandatory Medicaid Cost of Dispensing Surveys are due back to Myers & Stauffer on November 16. Myers and Stauffer mailed and emailed the surveys to pharmacies on October 19. You can access the survey documents, download an electronic version, and find instructions for responding on behalf of multiple locations on Myers & Stauffer’s Minnesota webpage.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
North Carolina
The mandate for health care organizations and providers that serve state-funded patients to connect to the state-designated HIE by January 1, 2023, is fast approaching. The legislative changes enacted in the 2022 Appropriations Act may leave organizations and providers with questions about their connection status. Our General FAQs on NC HealthConnex gives more answers about the impacts on NC HealthConnex participants and non-participants.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
Ohio
This week, ODM (Ohio Department of Medicaid) (Ohio Department of Medicaid) reversed its policy that required provider participation in the Vaccines for Children (VFC) program under the SPBM (Single Pharmacy Benefit Manager), Gainwell. To increase access to pediatric vaccines, Gainwell announced they will now cover pediatric vaccine claims by non-VFC providers, reimbursing product costs and an administration fee. NACDS worked jointly with the Ohio Council of Retail Merchants and members to advocate for this policy with both ODM and the Governor’s office.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Oklahoma
The Board of Pharmacy alerted licenses that the Oklahoma Board of Medical Licensure and Supervision (OMLS) has interpreted the laws and rules for Physician Assistants (PAs) prescribing Schedule II prescriptions. OMLS interpretation is that PA's can only prescribe Schedule II drug orders for immediate or on-going administration on-stie, which they define as a hospital, emergency room, ambulatory surgery center, medical clinic, or office in cases of emergency, or state-owned VA long term care facilities with an in-house pharmacy. PAs cannot prescribe Schedule II prescriptions in an outpatient setting for dispensing by a retail pharmacy.
Also in Oklahoma, the Board of Pharmacy will be closed November 30-December 2 so that they can move back to their newly renovated offices at 2920 N. Lincoln Blvd. Ste. A, Oklahoma City, OK 73105.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Oregon
The Board of Pharmacy is seeking applications from persons interested in serving on a workgroup concerning pharmacy interns. For more information, including the online application, visit the “Rules Advisory Committee (RAC) & Workgroup Information” webpage.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Pennsylvania
Gov. Tom Wolf (D) signed HB 1630 last week, just one day after the bill passed the General Assembly. HB 1630 allows the Auditor General access to PBM (Pharmacy Benefit Manager) data in the Medicaid Managed Care Program to perform audits. Notably, with the intent of expanding access to drug therapies, the bill was amended in the Senate Health Committee to repeal the provision in Section 1121.53(c) of 55 Pa. Code that limits payment for prescriptions in Medical Assistance to a 34-day supply or 100 units. Additionally, the following bills of interest to pharmacy were also signed:
- SB (Senate Bill) 225 (Act 146 of 2022) makes changes to prior authorization procedures and requires one form of MAT to be covered by Medicaid and private insurance without prior authorization requirements,
- HB 1393 (Act 111 of 2022) decriminalizes the use of fentanyl test strips for personal use and
- SB 1201 (Act 162 of 2022) requires health insurance policies to provide coverage for prescription eye drop refills at 70% of the prescription duration
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Rhode Island
Please see Medicaid Program November 2022 provider update.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
South Carolina
To comply with provisions of the Families First Coronavirus Response Act, the South Carolina Department of Health, and Human Services (SCDHHS) paused the typical annual eligibility review process for the state’s Healthy Connections Medicaid members effective January 27, 2020. When the current federal COVID-19 public health emergency (PHE) ends, state Medicaid agencies will be required to resume reviewing the eligibility of all Medicaid members. For more information, click here.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
South Dakota
The Board of Pharmacy distributed its October 2022 newsletter. Below is an outline of the content.
- Board Welcomes Newly Registered Pharmacists and Pharmacies
- SD Hosts NABP/AACP District 5 Meeting
- PDMP Statistical Report
- Board of Pharmacy Meeting Dates, Members and Staff
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Texas
NACDS, the Texas Federation of Drug Stores (TFDS), the Texas Pharmacy Association (TPA) and the Texas Health-Systems Pharmacists (TSHP) collaborated on November 2 for an all-day successful Pharmacy Advocacy Training Day at the Texas State Capitol. Pharmacists from around the state were briefed on the pharmacy priority issues for the 2023 legislative session, heard from legislators, regulators, on "how to advocate" effectively, and then practiced what they learned by role playing. Media pundits shared their stories on Texas politics, the November 8 elections, and the outlook for the 2023 session. Chain, independent and hospital pharmacists teamed up and spent the afternoon fanning out across the Capitol in teams putting their knowledge into practice with over 50 scheduled meetings with legislators and staff.
Also in Texas, the Health, and Human Service Commission (HHSC) is hosting a provider online seminar at Noon on November 8 on COVID-19 updates. COVID-19 vaccine providers may also benefit from the information relating to COVID-19 vaccine updates, clinical guidance, and product ordering. Please register to receive information to participate in this event.
Finally in Texas, the Board of Pharmacy adopted non-sterile compounding rules at its August meeting. Board rule 291.131 changes including new definitions of cleaning and sanitizing and calibrations of scales.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
Utah
The Board of Pharmacy posted the following:
- August 23 Signed Meeting Minutes
- Notice of November 15 meeting at 8:30 a.m. – Agenda Pending
- Notice of December 20 meeting at 8:30 a.m. – Agenda Pending
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Virginia
DMAS (Department of Medical Assistance Services) has issued a memo informing pharmacy providers that DMAS fee-for-service (FFS) and the Medicaid Managed Care Organizations will provide up to five professional dispense fees per month (defined as a rolling 30-day period) for buprenorphine-based opioid use disorder (OUD) products, effective December 1, 2022.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
Wisconsin
The Department of Safety and Professional Services announced it earned a $1.4 million grant from the Federal Bureau of Justice Assistance for its Enhanced Prescription Drug Monitoring Program (ePDMP). The grant funds will be used to modernize the self-service functionality and provide improved data quality, better customer support and greater user satisfaction.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
Alabama
Reminder, Alabama Administrative Rule 420-4-1-.04 requires pharmacists to report to the State Health Officer or designee the dispensing of anti-tuberculosis medications and dispensing of antiretroviral medications to an infant.
Also in Alabama, all previously published expiration dates related to the COVID-19 public health emergency (PHE) are once again extended by the Alabama Medicaid Agency. The new expiration date is the earlier of November 30, 2022, the conclusion of the COVID-19 national emergency, or any expiration date noticed by the Alabama Medicaid Agency through a subsequent ALERT.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
California
The Department of Health Care Services posted the following alerts and weekly notices on the Medi-Cal Rx Web Portal.
- Coverage of Sterile Syringes with Needles (Non-Insulin) (October 26)
- Reminder for Providers Regarding Patient Privacy (October 26)
- Historical Pricing and Reimbursement Corrections for Ixinity, Alprolix, Eloctate, and NovoSeven 4Q 2021 through Q3 2022 (October 25)
- Bivalent COVID-19 Vaccines Administration Now a Benefit (October 21)
- Medical Rx Weekly Wrap-Up for October 14-21 (October 21)
Also in California, the Board of Pharmacy issued its Annual Notice of Availability of Precedential Decisions Index. The index and the text of the precedential decisions are available on the Board’s webpage.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Kentucky
Patients and pharmacies in the Commonwealth took a giant leap forward this week when Anthem announced they will be enrolling pharmacists as network providers. The move is a result of the enactment of a law that provides for pharmacy payment parity; HB 48 of 2021 required Kentucky health plans to reimburse pharmacists for services within a pharmacist’s scope of practice that are otherwise covered by the plan, if provided by another healthcare provider. Coupled with a pharmacist’s current authority to provide more than a dozen clinical services under Board of Pharmacy Protocols, Anthem members will have widespread convenient access to treatment at pharmacies for ailments such as flu, strep and tobacco cessation. Pharmacies interested in enrolling in the network should contact kyprovidercontracting@anthem.com. For more information, please see the Kentucky Pharmacists Association’s (KPhA’s) latest news release. NACDS applauds KPhA for its work with Anthem and its leadership in our joint support for HB 48.
Also in Kentucky, Medicaid has proposed a rule that may make it easier for pharmacies to provide vaccine services to kids with Medicaid coverage. The rule change eliminates the requirement to use Vaccines for Children (VFC) stock and strikes current language that states Medicaid will not reimburse for the cost of any vaccine if already available through the VFC program. NACDS interprets this to mean that pharmacies do not have to be enrolled in VFC to immunize and be reimbursed for Medicaid-covered kids. NACDS is seeking member feedback to determine whether this change would be significant to your vaccination efforts. Please review this rule and send Jill McCormack your comments by November 18.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
